Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,300 | 7 | 92.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,871 | 3 | 5.3% |
| Travel and Lodging | $686.66 | 2 | 2.0% |
| Food and Beverage | $154.94 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $15,600 | 3 | $0 (2022) |
| Alkermes, Inc. | $13,842 | 7 | $0 (2019) |
| Boehringer Ingelheim Pharma GmbH & Co.KG | $1,871 | 3 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,850 | 1 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $1,850 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,700 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($1,850) |
| 2022 | $5,200 | 2 | Sunovion Pharmaceuticals Inc. ($5,200) |
| 2021 | $10,400 | 1 | Sunovion Pharmaceuticals Inc. ($10,400) |
| 2019 | $8,342 | 6 | Alkermes, Inc. ($8,342) |
| 2018 | $5,500 | 1 | Alkermes, Inc. ($5,500) |
| 2017 | $1,871 | 3 | Boehringer Ingelheim Pharma GmbH & Co.KG ($1,871) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| 07/11/2024 | Sumitomo Pharma America, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| 05/26/2022 | Sunovion Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,850.00 | General |
| 03/17/2022 | Sunovion Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $3,350.00 | General |
| 05/06/2021 | Sunovion Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $10,400.00 | General |
| 04/29/2019 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 03/30/2019 | Alkermes, Inc. | — | Travel and Lodging | In-kind items and services | $539.60 | General |
| 03/30/2019 | Alkermes, Inc. | — | Travel and Lodging | In-kind items and services | $147.06 | General |
| 03/30/2019 | Alkermes, Inc. | — | Food and Beverage | In-kind items and services | $59.98 | General |
| 03/30/2019 | Alkermes, Inc. | — | Food and Beverage | In-kind items and services | $49.97 | General |
| 03/30/2019 | Alkermes, Inc. | — | Food and Beverage | In-kind items and services | $44.99 | General |
| 11/19/2018 | Alkermes, Inc. | Aristada 441 mg (Drug), Aristada 662mg, Aristada 882mg | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: CNS | ||||||
| 05/19/2017 | Boehringer Ingelheim Pharma GmbH & Co.KG | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $770.00 | General |
| 03/10/2017 | Boehringer Ingelheim Pharma GmbH & Co.KG | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $752.00 | General |
| 01/12/2017 | Boehringer Ingelheim Pharma GmbH & Co.KG | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $349.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 39 | $10,491 | $3,059 |
| 2022 | 1 | 13 | 29 | $7,877 | $2,047 |
| 2021 | 2 | 26 | 71 | $15,259 | $5,194 |
| 2020 | 2 | 29 | 81 | $10,828 | $3,368 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 12 | 39 | $10,491 | $3,059 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 29 | $7,877 | $2,047 | 26.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 42 | $10,290 | $3,656 | 35.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 12 | 29 | $4,969 | $1,538 | 31.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 17 | 49 | $6,863 | $1,928 | 28.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 12 | 32 | $3,965 | $1,441 | 36.3% |
About Dr. David Henderson, MD
Dr. David Henderson, MD is a Psychiatry healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1699759076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Henderson, MD has received a total of $35,013 in payments from pharmaceutical and medical device companies, with $3,700 received in 2024. These payments were reported across 15 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($32,300).
As a Medicare-enrolled provider, Henderson has provided services to 80 Medicare beneficiaries, totaling 220 services with total Medicare billing of $13,668. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Boston, MA
- Active Since 11/30/2005
- Last Updated 12/12/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1699759076
Products in Payments
- Aristada 441 mg (Drug) $5,500
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Boston
Dr. Maurizio Fava, Md, MD
Psychiatry — Payments: $248,730
Dr. George Papakostas, Md, MD
Psychiatry — Payments: $190,290
Dr. Robert Birnbaum, Md, Phd, MD, PHD
Psychiatry — Payments: $182,500
Dr. Andrew Nierenberg, Md, MD
Psychiatry — Payments: $165,058
Dyanna Domilici, M.d, M.D
Psychiatry — Payments: $91,278
Dr. Lee Goldstein, M.d., Ph.d, M.D., PH.D
Psychiatry — Payments: $90,000